Yoga and MBSR for TTH

April 1, 2025 updated by: Holger Cramer, Universität Duisburg-Essen

Yoga and Mindfulnes-based-stress-reduction for Patients With Tension-type Headache

Primary study objectives

  1. evaluate the short-term effect of yoga intervention in addition to routine care on headache frequency in patients with frequent or chronic tension-type headache compared to routine care alone (waiting group).
  2. to evaluate the short-term effect of yoga intervention in addition to routine care on headache frequency in patients with frequent episodic or chronic tension-type headache compared with stress management through mindfulness-based stress reduction (MBSR) in addition to routine care.

Secondary study objectives

Evaluation of the medium-term effect of the intervention on headache frequency as well as the short- and medium-term effect on the secondary target parameters in comparison to the waiting group and MBSR. Further evaluation of the safety and acceptability of the intervention.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Completed

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Interventional

Enrollment (Actual)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
72

Phase

Phase

The stage of a clinical trial studying a drug or biological product, based on definitions developed by the U.S. Food and Drug Administration (FDA). The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4. Not Applicable is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.
  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact

The name and contact information for the person who can answer enrollment questions for a clinical study. Each location where the study is being conducted may also have a specific contact, who may be better able to answer those questions.

Study Contact Backup

Study Locations

  • Germany
    • Northrhine-Westphalia
      • Essen, Northrhine-Westphalia, Germany, 45276
        • Evang. Kliniken Essen-Mitte

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • episodic or chronic tension-type headache according to ICHD-3 definition

Exclusion Criteria:

  • medication induced headache according to ICHD-3 definition
  • Cluster-headache according to ICHD-3 definition
  • serious chronic systemic or acute physical or mental illness
  • Dementia
  • Pregnancy
  • actual in a yoga or MBSR class

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm

Participant Group / Arm

A group or subgroup of participants in a clinical trial that receives a specific intervention/treatment, or no intervention, according to the trial's protocol.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Experimental: Iyengar Yoga Intervention

8-week yoga class; once weekly; 90 minutes

Note: First administered face-to-face, due to Covid-restrictions changed to online classes
Behavioral: Iyengar Yoga
Classical Iyengar Yoga intervention, especially designed for headache patients. Note: First administered face-to-face, due to Covid-restrictions changed to online classes
Active Comparator: Mindfulness-based stress reduction

8-week MBSR class; once weekly; 90 minutes

Note: First administered face-to-face, due to Covid-restrictions changed to online classes
Behavioral: Mindfulness-based stress reduction
Standardazied Mindfulness-based stress reduction intervention Note: First administered face-to-face, due to Covid-restrictions changed to online classes
No Intervention: Waitlist control
Waitlist control, ususal care

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Headache Frequency
Time Frame: post-intervention (8 weeks)
Headache Frequency self-reported by a headache diary
post-intervention (8 weeks)

Secondary Outcome Measures

Secondary Outcome Measures

In a clinical study's protocol, a planned outcome measure that is not as important as the primary outcome measure for evaluating the effect of an intervention but is still of interest. Most clinical studies have more than one secondary outcome measure.
Outcome Measure
Measure Description
Time Frame
Headache Frequency
Time Frame: follow-up (20 weeks)
Headache Frequency self-reported by a headache diary
follow-up (20 weeks)
Duration of headache episodes
Time Frame: post-intervention (8 weeks)
Duration of headache episodes self-reported by a headache diary
post-intervention (8 weeks)
Duration of headache episodes
Time Frame: follow-up (20 weeks)
Duration of headache episodes self-reported by a headache diary
follow-up (20 weeks)
Pain Intensity
Time Frame: post-intervention (8 weeks)
Numeric rating scale
post-intervention (8 weeks)
Pain Intensity
Time Frame: follow-up (20 weeks)
Numeric rating scale (NRS)
follow-up (20 weeks)
Pain medication use
Time Frame: post-intervention (8 weeks)
Pain medication use self-reported by a headache diary
post-intervention (8 weeks)
Pain medication use
Time Frame: follow-up (20 weeks)
Pain medication use self-reported by a headache diary
follow-up (20 weeks)
Headache related disability
Time Frame: post-intervention (8 weeks)
Headche Impact Test 6 (HIT-6)
post-intervention (8 weeks)
Headache related disability
Time Frame: follow-up (20 weeks)
Headche Impact Test 6 (HIT-6)
follow-up (20 weeks)
Health-related quality of life
Time Frame: post-intervention (8 weeks)
SF-36 questionaire
post-intervention (8 weeks)
Health-related quality of life
Time Frame: follow-up (20 weeks)
SF-36 questionaire
follow-up (20 weeks)
Anxiety
Time Frame: post-intervention (8 weeks)
Depression and Anxiety scale (DAAS)
post-intervention (8 weeks)
Anxiety
Time Frame: follow-up (20 weeks)
Depression and Anxiety scale (DAAS)
follow-up (20 weeks)
Stress
Time Frame: post-intervention (8 weeks)
Depression and Anxiety scale (DAAS)
post-intervention (8 weeks)
Stress
Time Frame: follow-up (20 weeks)
Depression and Anxiety scale (DAAS)
follow-up (20 weeks)
Pain catastrophizing
Time Frame: post-intervention (8 weeks)
Pain catastrophizing scale (PCS)
post-intervention (8 weeks)
Pain catastrophizing
Time Frame: follow-up (20 weeks)
Pain catastrophizing scale (PCS)
follow-up (20 weeks)
Pain acceptance
Time Frame: post-intervention (8 weeks)
Chronic pain acceptance questionaire (CPAQ)
post-intervention (8 weeks)
Pain acceptance
Time Frame: follow-up (20 weeks)
Chronic pain acceptance questionaire (CPAQ)
follow-up (20 weeks)
Mindfulness
Time Frame: post-intervention (8 weeks)
Mindfulness Attention and Awerness scale (MAAS)
post-intervention (8 weeks)
Mindfulness
Time Frame: follow-up (20 weeks)
Mindfulness Attention and Awerness scale (MAAS)
follow-up (20 weeks)
Body Awareness
Time Frame: post-intervention (8 weeks)
Body Awareness questionaire (BAQ)
post-intervention (8 weeks)
Body Awareness
Time Frame: follow-up (20 weeks)
Body Awareness questionaire (BAQ)
follow-up (20 weeks)
Safety
Time Frame: post-intervention (8 weeks)
Adverse events
post-intervention (8 weeks)
Safety
Time Frame: follow-up (20 weeks)
Adverse events
follow-up (20 weeks)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Universität Duisburg-Essen

Collaborators

Collaborators

An organization other than the sponsor that provides support for a clinical study. This support may include activities related to funding, design, implementation, data analysis, or reporting.
Eden Stiftung

Investigators

Investigators

A researcher involved in a clinical study. Related terms include site principal investigator, site sub-investigator, study chair, study director, and study principal investigator.
  • Study Chair: Gustav Dobos, MD, University of Duisburg-Essen, Faculty of Medicine

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
February 1, 2019

Primary Completion (Actual)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
August 30, 2021

Study Completion (Actual)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
December 30, 2021

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
April 29, 2021

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
April 29, 2021

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
April 30, 2021

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
April 4, 2025

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
April 1, 2025

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
April 1, 2025

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • 17-7925 BO

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Tension-Type Headache

Clinical Trials on Iyengar Yoga

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings